News
In 2024, the ataxia market was valued at USD 37.70 billion. With growing research and drug approvals, this market is projected to expand at a 9.72% C ...
In this video, Khalaf Bushara, MD, FRCP, discusses therapies in the pipeline that show promise for the treatment of Friedriech's ataxia.
Michael Gehr, of Edmond, and his family are on a mission to help find a cure for a rare genetic disease that he was diagnosed with at age 15.
Huntington’s disease and Friedreich’s ataxia are part of a group of neurological disorders dubbed trinucleotide repeat disorders because they are caused by repeating three-letter stretches of DNA.
Quince Therapeutics advances Ataxia-Telangiectasia treatment with innovative AIDE platform, insider support, and NEAT Phase 3 trial data expected early 2026.
Ataxia is caused by damage in cerebellum, leading to poor muscle control. Know the causes and types of ataxia that can lead to other health complications.
In this video David Lynch, MD, PhD, discusses current treatment options for Friedreich's ataxia patients.
The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for vatiquinone for the treatment of children and ...
In some cases, an inability to balance is referred to as a symptom known as ataxia. But ataxia can also be its own condition or disease.
Bill Nye, one of the nation's most popular scientists is headed to Capitol Hill to bring awareness to Ataxia.
Ataxia, often misdiagnosed as Parkinson's or MS, has affected Bill Nye's family — and now he's spreading the word on genetic testing.
Several months after forging a path forward for its Friedreich ataxia drug vatiquinone, PTC Therapeutics is back with some much-needed good news.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results